ALPN लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (18 May 2024 @ 01:30):
Our systems believe the stock currently is undervalued by 0.11% compare to its pairs and should correct upwards.

Stats
आज की मात्रा	4.29M
औसत मात्रा	2.37M
बाजार मूल्य	4.46B
EPS	$-0.280 ( Q1 \| 2024-05-09 )
अगली कमाई की तारीख	( $-0.420 ) 2024-08-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-101.52 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00600 (0.01%)

AADI -2.65%

ABCL 1.47%

ABCM 0.04%

ABEO -2.37%

ABIO -1.68%

ABOS 1.64%

ABSI 3.06%

ABUS -2.24%

ABVX -3.53%

ACAD -0.51%

ACER -17.95%

ACET -4.42%

ACGN 1.29%

ACHL -4.15%

ACHV -1.72%

ACIU -1.00%

ACLX -0.09%

ACRV -4.79%

ACST -1.63%

ACXP 0.65%

ADAG 4.64%

ADAP -2.79%

ADGI 0.87%

ADIL 0.54%

ADMA -2.59%

ADPT -0.30%

ADTX -3.47%

ADVM -4.29%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -1.40%

AGEN -1.58%

AGIO -2.04%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.54%

AKRO -2.77%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.11%

ALEC -3.90%

ALGS -2.41%

ALKS -0.21%

ALLK -8.47%

ALLO -6.47%

ALLR -3.17%

ALNA 3.16%

ALNY 1.79%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -9.11%

ALVR -0.58%

ALXN 0.00%

ALXO -10.65%

ALZN 4.78%

AMRN 0.26%

AMTI -3.13%

ANAB 0.50%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.65%

ANPC -3.15%

APGE -1.01%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.02%

APLT -4.28%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 4.70%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -3.69%

ARDS -14.23%

ARDX -0.58%

ARGX -0.80%

ARNA 0.00%

ARPO -0.90%

ARQT -0.50%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.36%

ARWR -1.86%

ASLN -4.71%

ASMB -7.14%

ASND -0.91%

ATAI -1.12%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.99%

ATOS 2.91%

ATRA -2.89%

ATXI 1.93%

ATXS -1.22%

AUPH -0.99%

AURA -0.15%

AUTL -1.72%

AVBP -2.86%

AVEO 0.00%

AVIR -0.15%

AVRO -1.41%

AVTE -4.83%

AVTX -1.25%

AVXL -2.72%

AXLA 0.00%

AXSM -1.75%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.81%

BCAB 3.59%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 2.60%

BCRX 1.32%

BCTX 8.12%

BCTXW -22.52%

BCYC 0.85%

BDRX -4.65%

BDTX -0.85%

BEAM 0.24%

BFRA -2.91%

BGNE -2.19%

BIOR -3.40%

BIVI 1.27%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.66%

BMEA -9.88%

BMRN 0.36%

BNOX -2.22%

BNTC -2.11%

BNTX -1.26%

BOLD -7.90%

BOLT -0.18%

BPMC -1.19%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 23.61%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.33%

CABA 0.76%

CADL -0.97%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -2.40%

CARA 0.21%

CARM 12.16%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -7.00%

CCCC -5.40%

CCXI 0.00%

CDAK 0.00%

CDIO -2.02%

CDIOW 24.00%

CDMO -2.96%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC -0.41%

CDXS 4.48%

CELC -3.85%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -0.86%

CERO -3.60%

CEROW -10.18%

CFRX -27.95%

CGEM -2.74%

CGEN -2.79%

CGON -0.29%

CGTX -5.11%

CHMA -6.00%

CHRS 0.00%

CINC 0.00%

CING -3.70%

CINGW 34.95%

CKPT -2.88%

CLBS -16.75%

CLDX -2.27%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.24%

CLSD 1.60%

CLSN -0.68%

CLVS 0.00%

CMMB -0.01%

CMND 3.63%

CMPI 0.00%

CMPX -8.03%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -40.07%

CNST 0.00%

CNTA -0.68%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -2.88%

CORT 2.17%

COYA -1.46%

CPRX -0.76%

CRBP -1.89%

CRBU -4.84%

CRDF -1.77%

CRGX 1.28%

CRIS -0.38%

CRNX -5.62%

CRSP 1.03%

CRTX 2.63%

CRVO -2.50%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -2.50%

CTNM -0.65%

CTXR 1.03%

CUE 3.53%

CVAC -2.25%

CVKD -5.23%

CWBR 2.80%

CYAD -12.96%

CYCC 9.75%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -2.06%

CYTO -2.73%

DARE 7.54%

DAWN 0.75%

DBTX -0.81%

DBVT 4.44%

DFFN 10.28%

DICE 0.06%

DMAC 34.38%

DNLI -1.90%

DNTH -6.35%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.51%

DTIL 1.36%

DYAI 9.68%

EARS -1.77%

EDIT -2.42%

EDSA -1.00%

EFTR 7.18%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -4.56%

ELOX 7.69%

ELTX -0.88%

ELVN -3.87%

ELYM 1.05%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 5.11%

ENTA -0.49%

ENTO -0.07%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.57%

ETON 1.49%

ETTX 0.00%

EVAX -2.14%

EVGN 3.88%

EVLO 0.00%

EWTX -0.01%

EXAI -0.95%

EXEL -0.25%

EYEG -0.69%

EYEN 1.48%

EYPT -0.12%

FATE -8.06%

FBIO 0.59%

FBIOP 0.92%

FBLG -15.70%

FBRX -0.04%

FDMT -4.73%

FENC -1.29%

FGEN -5.53%

FHTX 1.43%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.58%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.36%

FULC -3.34%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.29%

GANX -0.78%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.09%

GHRS -1.59%

GLMD -2.15%

GLPG -2.26%

GLSI 2.80%

GLTO -0.57%

GLUE -1.58%

GLYC -10.03%

GMAB -0.47%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.52%

GNLX 0.89%

GNPX 0.00%

GNTA 3.94%

GOSS -8.90%

GOVX 5.00%

GOVXW -49.04%

GPCR -6.47%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 0.00%

GRTX 0.00%

GTHX 0.68%

GUTS -5.31%

GXGXW 41.67%

GYRE -7.16%

HALO -0.89%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -1.91%

HOOK 1.13%

HOTH -2.70%

HOWL -2.14%

HRMY 0.83%

HRTX 1.80%

HSTO 0.00%

HUMA 1.01%

HUMAW -0.01%

IBRX -4.26%

ICCC 0.22%

ICPT 0.21%

ICU 16.84%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.52%

IFRX -1.85%

IGMS -0.15%

IKNA 0.60%

IKT 1.42%

IMAB -0.87%

IMCR -2.60%

IMGN 0.02%

IMGO 0.00%

IMMP 4.55%

IMMX -6.90%

IMNM -1.56%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.70%

IMTX -1.58%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.77%

INAB 0.59%

INBX 0.47%

INCY -0.94%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -2.20%

INMB 2.66%

INO -1.81%

INSM -0.87%

INTS -2.75%

INVA 0.22%

INZY 1.14%

IOBT -11.37%

IONS 0.15%

IOVA -2.19%

IPA 2.46%

IPHA 5.58%

IPSC -1.95%

IRON -2.35%

ISEE 0.38%

ITOS -1.44%

ITRM 1.67%

IVA 6.96%

IVVD -4.12%

JAGX 1.04%

JANX -4.02%

JAZZ -0.55%

JNCE 0.00%

JSPR -5.92%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -1.90%

KDNY 0.22%

KMPH -0.34%

KNSA -2.71%

KNTE -0.38%

KOD -6.75%

KPRX 0.96%

KPTI -1.83%

KRBP -10.00%

KRON 1.05%

KROS -1.18%

KRRO -6.34%

KRTX 0.03%

KRYS -0.99%

KTRA 16.96%

KTTA 8.16%

KTTAW 0.92%

KURA -1.83%

KYMR -2.22%

KYTX -3.49%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -1.33%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.65%

LENZ -4.01%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -9.04%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.87%

LPCN -3.16%

LPTX -1.10%

LQDA -0.24%

LRMR -1.78%

LSTA -4.06%

LTRN 1.76%

LUMO -1.32%

LVTX 0.00%

LXEO -4.33%

LXRX -2.06%

LYEL -34.83%

LYRA 2.71%

MACK 0.10%

MBIO -9.39%

MBRX -1.72%

MCRB 1.12%

MDGL -2.42%

MDNA -13.16%

MDWD 0.10%

MDXG -2.58%

MEIP -0.13%

MESO -1.78%

MGNX -3.03%

MGTA -7.74%

MGTX -2.68%

MGX -2.68%

MIRM -1.16%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.76%

MLYS -5.63%

MNKD -1.05%

MNMD 0.14%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.06%

MORF -3.67%

MREO -4.42%

MRKR 2.68%

MRNA -4.97%

MRNS -4.04%

MRSN -2.62%

MRTX -0.17%

MRUS 0.18%

MRVI -1.82%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -1.08%

MYMD 8.38%

NAMS 1.37%

NAMSW 0.43%

NAUT 1.14%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.87%

NEXI 2.60%

NGM -1.28%

NGNE -1.98%

NKGN 5.88%

NKGNW 8.00%

NKTR -3.74%

NKTX -4.57%

NLSP -2.77%

NLSPW 26.67%

NMRA -0.46%

NMTR -42.97%

NOVN -24.84%

NRBO 11.03%

NRIX -0.58%

NRSN -7.05%

NRSNW 0.00%

NRXP -4.14%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.19%

NTRBW -31.07%

NUVL -1.93%

NVAX -1.93%

NVCT 3.59%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.40%

OABIW -10.06%

OBIO -2.99%

OBSV 0.00%

OCEA 0.00%

OCGN 4.27%

OCS -1.02%

OCUL -1.91%

OCUP 1.97%

ODT -4.27%

OKYO 1.51%

OLMA -5.20%

OMER -0.90%

OMGA 5.42%

ONCO 4.90%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 3.09%

ORGS -2.07%

ORIC -3.56%

ORMP 15.09%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.43%

OYST 0.00%

PALI -0.87%

PASG -1.30%

PBLA -7.50%

PBM -7.64%

PBYI 1.69%

PCSA 0.00%

PCVX -0.37%

PDSB -1.11%

PEPG 0.48%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -3.57%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.73%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT -4.26%

PRAX 0.95%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.45%

PRQR -0.01%

PRTA -2.31%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.11%

PSTX -1.16%

PTCT -0.28%

PTE -0.82%

PTGX -1.70%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 2.28%

QLGN -3.67%

QNCX 5.70%

QNRX 0.37%

QSI -11.92%

QSIAW -3.13%

QTTB -4.54%

QURE -0.22%

RAIN -1.63%

RANI 6.42%

RAPT -2.27%

RARE 1.10%

RCKT -8.09%

REGN -0.66%

RENB -3.11%

REPL -2.89%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -4.91%

RGNX -5.40%

RIGL -3.28%

RLAY -4.60%

RLMD 0.33%

RLYB -0.34%

RNA -0.42%

RNAC -5.65%

RNAZ -0.96%

RNXT 1.88%

ROIV -2.08%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.28%

RPTX -2.05%

RUBY 2.70%

RVLP -32.05%

RVMD -1.07%

RVMDW -30.00%

RVNC 1.70%

RVPH -1.19%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.36%

RYTM -6.25%

RYZB 0.02%

RZLT 1.29%

SABS -1.37%

SABSW -11.81%

SAGE 1.56%

SANA -4.06%

SAVA -0.26%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH -0.51%

SCPS 0.00%

SEEL -4.48%

SEER -0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.01%

SGMT -1.93%

SGTX -2.56%

SIOX 22.63%

SLDB -5.17%

SLGL 4.00%

SLN -4.01%

SLNO -2.93%

SLRX 5.23%

SLS -2.99%

SMMT -2.87%

SNDX 0.82%

SNGX -3.02%

SNPX -0.81%

SONN -1.08%

SPPI -0.49%

SPRB 0.30%

SPRC -4.17%

SPRO 0.30%

SRNE -34.00%

SRPT -1.85%

SRRA 0.00%

SRRK -2.60%

SRZN -2.45%

STAB 0.00%

STOK -5.02%

STRO -2.51%

STSA 0.00%

STTK -4.78%

SURF -0.93%

SVRA -3.31%

SWTX 0.71%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -8.06%

TARS 0.12%

TBPH 0.48%

TCBP 2.73%

TCDA 0.00%

TCON -2.43%

TCRR 0.00%

TCRT 1.59%

TCRX 2.58%

TECH -0.05%

TENX -1.27%

TERN -7.59%

TFFP -3.05%

TGTX -2.81%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -4.13%

TNGX -2.16%

TNXP -6.39%

TNYA -8.76%

TPST 2.31%

TRDA -3.86%

TRVI 1.15%

TRVN 5.02%

TSHA -23.94%

TSVT -3.19%

TTNP -9.27%

TVTX 0.63%

TYRA -7.11%

UBX -2.12%

UNCY -3.38%

URGN -1.45%

UTHR -0.32%

VACC 11.36%

VALN -2.89%

VAXX 87.50%

VBIV 0.78%

VBLT -8.77%

VCEL -0.09%

VCNX 10.35%

VCYT -1.23%

VERA -2.81%

VERU 0.78%

VERV -2.87%

VIGL 5.11%

VINC 1.62%

VIR 0.33%

VIRI -1.57%

VIRX 2.40%

VKTX -1.36%

VLON -13.04%

VNDA -2.20%

VOR -2.02%

VRCA 0.28%

VRDN -4.23%

VRNA -1.00%

VRPX 0.38%

VRTX 0.35%

VSTM -3.74%

VTGN -0.45%

VTVT -2.97%

VTYX -0.21%

VXRT -2.26%

VYGR -1.66%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.61%

XBIO 0.93%

XBIT 0.21%

XCUR 3.58%

XENE -2.91%

XERS 2.39%

XFOR 3.71%

XLO 2.23%

XLRN 0.00%

XNCR 0.34%

XOMA -3.14%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.92%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.46%

ZNTL -2.86%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-05-20	Peetz Christopher	Sell	1 900	Common Stock
2024-05-20	Peetz Christopher	Sell	7 650	Stock Option (Right to buy)
2024-05-20	Peetz Christopher	Sell	7 650	Stock Option (Right to buy)
2024-05-20	Peetz Christopher	Sell	7 650	Stock Option (Right to buy)
2024-05-20	Peetz Christopher	Sell	7 650	Stock Option (Right to buy)

INSIDER POWER
-99.05
Last 100 transactions
Buy: 62 882 \| Sell: 12 958 869

सहसंबंध (AI algo v.1.1b): Undervalued: 0.11% $65.05 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

मात्रा सहसंबंध

लंबा: -0.02 (neutral)

छोटा: -0.45 (neutral)

Signal:(40.808) Neutral

Alpine Immune Sciences सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
NKTR	0.961
BCSA	0.956
IVCB	0.949
NSYS	0.949
BOCN	0.946
GDST	0.941
PRIM	0.939
PAYS	0.938
GALT	0.937
RZLT	0.936

10 सबसे अधिक नकारात्मक सहसंबंध
ALLR	-0.966
JACK	-0.959
PERI	-0.958
AKTX	-0.954
WNEB	-0.953
SIRI	-0.952
APVO	-0.95
HAIN	-0.948
XPON	-0.948
OSUR	-0.948

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Alpine Immune Sciences सहसंबंध - मुद्रा/वस्त्र

0.43
( neutral )

0.26
( neutral )

0.00
( neutral )

0.08
( neutral )

Alpine Immune Sciences वित्तीय

Annual	2023
राजस्व:	$58.88M
सकल लाभ:	$58.30M (99.02 %)
EPS:	$-0.640

FY	2023
राजस्व:	$58.88M
सकल लाभ:	$58.30M (99.02 %)
EPS:	$-0.640

FY	2022
राजस्व:	$30.06M
सकल लाभ:	$29.47M (98.01 %)
EPS:	$-1.730

FY	2021
राजस्व:	$23.44M
सकल लाभ:	$0.00 (0.00 %)
EPS:	$-1.980

Financial Reports:

No articles found.

Alpine Immune Sciences Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Alpine Immune Sciences

Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer; and ALPN-303, a dual B cell cytokine antagonist for the treatment of B cell-mediated inflammatory and autoimmune diseases. The company has a collaboration agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101; and Adaptimmune Therapeutics plc to develop next-generation SPEAR T cell products. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.